In vitro and in vivo assessment of humic acid as an aflatoxin binder in broiler chickens

Poult Sci. 2006 Sep;85(9):1576-83. doi: 10.1093/ps/85.9.1576.

Abstract

The in vitro affinity and adsorption capacity of a humic acid, oxihumate, for aflatoxin B1 (AFB1) was evaluated, utilizing Langmuir and Freundlich adsorption isotherms. Oxihumate showed a high in vitro affinity for AFB1. The Freundlich isotherm fitted the data better than the Langmuir isotherm, and binding capacities of 10.3, 7.4, and 11.9 mg of AFB1/g of oxihumate at pH 3, 5, and 7, respectively, were calculated. The in vivo efficacy of oxihumate as an aflatoxin binder in male broiler chickens exposed to aflatoxin-contaminated feed from 7 to 42 d of age was also assessed. The efficacy of oxihumate was compared with a commercially available product with a brewers dried yeast (BDY) and brewers fermentation solubles as main active ingredients. A total of 420 birds were assigned to 28 pens, with 15 birds per pen. The following treatments were applied: 1) 0 mg of AFB1 + 0 additives, 2) 1 mg of AFB1/kg of feed + 0 additives, 3) 1 mg of AFB1/kg of feed + 3.5 g of oxihumate/kg of feed, 4) 1 mg of AFB1/kg of feed + 3.5 g of BDY/kg of feed, 5) 2 mg of AFB1/kg of feed + 0 additives, 6) 2 mg of AFB1/kg of feed + 3.5 g of oxihumate/kg of feed, and 7) 2 mg of AFB1/kg of feed + 3.5 g of BDY/kg of feed. Each treatment consisted of 4 replicates. Oxihumate was effective in diminishing the adverse effects caused by aflatoxin on BW of broilers (P < 0.05). Oxihumate also showed protective effects against liver damage, stomach and heart enlargement, as well as some of the hematological and serum biochemical changes associated with aflatoxin toxicity (P < 0.05). Results indicated that oxihumate, but not BDY, could alleviate some of the toxic effects of aflatoxin in growing broilers. Oxihumate might, therefore, prove to be beneficial in the management of aflatoxin-contaminated feedstuffs for poultry when used in combination with other mycotoxin management practices. Additional studies are warranted to assess its efficacy under a wide variety of circumstances.

Publication types

  • Clinical Trial

MeSH terms

  • Adsorption
  • Aflatoxin B1 / chemistry*
  • Aflatoxin B1 / metabolism
  • Aflatoxin B1 / toxicity*
  • Animal Feed* / analysis
  • Animals
  • Chickens / metabolism*
  • Dose-Response Relationship, Drug
  • Humic Substances* / analysis
  • Liver / drug effects
  • Liver / pathology
  • Male
  • Mycotoxicosis / prevention & control
  • Mycotoxicosis / veterinary*
  • Poultry Diseases / chemically induced*
  • Poultry Diseases / prevention & control
  • Weight Gain / drug effects

Substances

  • Humic Substances
  • oxihumate
  • Aflatoxin B1